Novartis considers selling its $5B+ ophthalmology and respiratory units — report

As Novartis has been focusing its core pipeline, and spinning off its generics arm Sandoz, the company may be looking to sell even more.

According to a report from Bloomberg today, the Swiss pharma is considering the sale of some of its “non-core” assets to raise...

Click to view original post